NCT00434096View on ClinicalTrials.gov

Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)

PHASE3TerminatedINTERVENTIONAL

Enrollment

915

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

February 28, 2009

Conditions

Obesity

Interventions

DRUG

rimonabant (SR141716)

oral administration once daily

DRUG

placebo

oral administration once daily

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY